Menopause Insomnia: Getting Effective Treatment

You may lie awake at bedtime, wake repeatedly, or wake early and struggle to sleep again. The effect can include fatigue, irritability, reduced concentration, and concern about the next night. The clinician needs to know whether the problem occurs despite enough time and a suitable environment for sleep.

Chronic insomnia generally involves difficulty at least three nights a week for three months or longer, with daytime effects. You do not need to wait for that duration if sleep loss is disrupting work, safety, or daily life. A one-to-two-week diary can record timing, awakenings, naps, sweating, and daytime sleepiness.

• Night sweating, pain, reflux, or frequent urination.
• Snoring, gasping, observed breathing pauses, or unrefreshing sleep.
• Anxiety, depression, major stress, and worry about sleep itself.
• Caffeine, alcohol, nicotine, and prescription or over-the-counter medicines.
• Changes in working hours or the time available for sleep.

Women with sleep apnea may report fatigue, morning headache, or insomnia. Tell the clinician about these symptoms even if the main complaint is lying awake. Examination and tests should be directed at suspected causes; a sleep study is useful for possible apnea and other sleep disorders, while routine insomnia diagnosis is largely based on the history.

Cognitive behavioral therapy for insomnia, or CBT-I, is usually the first treatment for persistent insomnia. It combines work on sleep-related thoughts with changes to routines and time in bed. A trained clinician or therapist uses your sleep history to choose and adjust the approach. Delivery can be in person, by telephone, or online.

You may work on linking bed with sleep, keeping a regular wake time, reducing prolonged wakefulness in bed, and responding differently to worries about a poor night. Time-in-bed adjustments need an appropriate plan, especially if you have significant sleepiness or other health conditions. Ask for guided treatment before making substantial changes to time in bed.

The 2026 American Academy of Sleep Medicine guideline supports CBT-I as a central treatment. It conditionally favors CBT-I plus medication over medication alone, but generally favors CBT-I alone over routinely adding medicine. Evidence certainty was low, so treatment goals and circumstances still matter.

HRT or an appropriate nonhormonal treatment can reduce menopause vasomotor symptoms. NICE also recommends considering menopause-specific CBT for sleep problems associated with those symptoms. If sweating improves but prolonged wakefulness continues, the insomnia still needs attention.

HRT should be selected for a suitable menopause indication after reviewing risks and preferences. It is not a universal prescription for every sleep complaint. Local vaginal estrogen treats vaginal and urinary symptoms and does not provide systemic hot-flash treatment.

Sleeping medicines differ in how long they act and whether they are appropriate for short or longer use. Review daytime impairment, falls, interactions, dependence risk for some products, and the plan for reassessment. Avoid combining sedating products or alcohol without advice.

FDA warns that eszopiclone, zaleplon, and zolpidem can cause rare complex sleep behaviors, including driving or other activities while not fully awake. Stop the medicine and contact the clinician immediately if this happens. These products should not be prescribed after a previous episode with one of them.

Over-the-counter antihistamines and supplements also need review. A product that causes sleepiness may still have adverse effects or inadequate evidence for insomnia. If you are too sleepy to drive safely, avoid driving and arrange assessment. New severe mood symptoms or suicidal thoughts require prompt mental-health care.